ArticleInternational journal of endocrinology and metabolism2026
No Evidence of Association Between Human 24-Hour Urinary Dopamine and Weight, BMI or Glucose Homeostasis in a Retrospective Analysis.
Article in International journal of endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dopamine is an essential neurotransmitter involved in motivation and reward. In obesity, altered dopaminergic responses to food may drive excess energy intake, implicating dopamine in the pathophysiology of obesity. Additionally, dopamine may act as an anti-incretin, potentially facilitating the development of type 2 diabetes. Objectives: This retrospective study investigated associations between urinary dopamine, weight, Body Mass Index (BMI), plasma glucose, and hemoglobin A1c (HbA1c). Methods: Twenty-four-hour urinary dopamine concentrations measured with liquid chromatography tandem mass spectrometry between January 2000 and October 2020 were retrieved from the University Hospitals Leuven clinical database. Records with dopamine disruption disorders or medications, psychiatric conditions, prior bariatric surgery, active malignancies, diabetes mellitus other than type 2 diabetes, chronic renal insufficiency, or urinary creatinine concentration outside the reference range were excluded, yielding 178 records. Spearman correlations and multiple linear regression models were performed; statistical significance was set at P < 0.05. Results: Twenty-four-hour urinary dopamine concentrations positively correlated with body weight and negatively with HbA1c, but these correlations became non-significant when corrected for age, sex, and estimated glomerular filtration rate (eGFR). The only remaining significant correlation was between age and twenty-four-hour urinary dopamine (β = -1.2, P = 0.030). Conclusions: No significant correlations were found between twenty-four-hour urinary dopamine and weight, BMI, or glucose homeostasis, potentially due to the absence of dietary control. As dopamine measurements came from a clinical database, generalizability is limited. Prospective dedicated studies are needed to disentangle the role of peripheral dopamine in the pathophysiology of obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.